Wolfgang Miesbach, Flora Peyvandi and Glenn F Pierce on Malignancy in Persons with Haemophilia
Michael Makris, Professor of Haemostasis and Thrombosis at University of Sheffield, Editor-in-Chief of Research and Practice in Thrombosis and Haemostasis, shared an insightful post on LinkedIn:
”There is an interesting discussion about the issue of malignancy in persons with haemophilia who have had gene therapy in the New England Journal this week.
The number of malignancies is increasing as more patients undergo gene therapy.
The key issues are:
a) Need for a standardised set of investigations
b) Need for advice on what tissue sample to collect and how to store them, to allow for the more specialised investigations
c) The interpretation of the results
d) Payment for these very expensive investigations. Manufacturers have funded these so far because most of the cases were seen in the clinical trials, but will they continue to fund it long term?”
Read the full article in NEJM.
Article: AAV Gene Therapy in Severe Hemophilia B
Authors: Wolfgang Miesbach, Flora Peyvandi, Glenn F Pierce
Saty updated on the latest scientific advances in the field of Hemophilia with Hemostasis Today.
-
Aug 21, 2025, 16:16Reza Shojaei on Redefining Blood Waste: The Future of Biotech and Healing
-
Aug 21, 2025, 16:01TAILORED-CHIP Trial: Time-Dependent Antiplatelet Therapy in High-Risk PCI
-
Aug 21, 2025, 15:54On the Chessboard of Blood Donation: Abdul Mannan Reviews a Complex Case
-
Aug 21, 2025, 15:31Flora Peyvandi on AI in Clinical Supervision: Educational Strategies
-
Aug 21, 2025, 15:28Lumbar Puncture Safety in Blood Cancers: Study Supports Platelet Count of 40 Instead of 50 - Haematologica
-
Aug 21, 2025, 15:48World Federation of Hemophilia on Inhibitors in Treatment
-
Aug 21, 2025, 14:00Wolfgang Miesbach, Flora Peyvandi and Glenn F Pierce on Malignancy in Persons with Haemophilia
-
Aug 20, 2025, 14:25Mattia Galli: Sex-related Differences in Platelet Reactivity in Patients Both On and Off Antiplatelet Therapy
-
Aug 20, 2025, 12:55Commentary from Giuseppe Lippi and Colleagues on Light Exposure, Platelet Function and Thrombus Formation
-
Aug 20, 2025, 05:48James Harte on Asundexian and Milvexian's Strong, Dose-dependent Interferences in Coagulation Assays
-
Aug 18, 2025, 23:56Dr. Arun V. J Invites You to His Lecture on ‘AI and Data Sciences in Transfusion Medicine’ at the AI in Healthcare Conclave. Register now!
-
Aug 18, 2025, 23:50Safe and Efficient Thrombectomy with Artix System: Clinical Insights from Neil Desai and Colleagues
-
Aug 16, 2025, 14:42Mark Crowther Honors Davide Matino for Leading Promising Hemophilia Trial at McMaster University
-
Aug 14, 2025, 10:28Impressive 95% Clot Removal in a VTE Case: Symphony16F and Symphony24F Catheters
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Aug 21, 2025, 15:08Global Variations in Blood Collection: What Explains the Differences?
-
Aug 20, 2025, 13:33Askat's Life with Hemophilia A after Access to Prophylactic Treatment Through the WFH Humanitarian Aid Program
-
Aug 19, 2025, 17:22Louise Bannon Encourages You to Support World Thrombosis Day!
-
Aug 17, 2025, 07:31Melissa Korn's story: Recognizing Pulmonary Embolism Symptoms Can Save Lives, NBCA
-
Aug 16, 2025, 14:18Christelle Orlando Highlights Breakthroughs in Thrombophilia Testing and AT Assays at ISTH 2025